Prostatitis treatment depends on which form of prostatitis is actually present. Acute and chronic bacterial prostatitis require infection-directed antibiotic treatment, while chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) usually needs a broader approach that may include alpha blockers for urinary symptoms, short-term pain or anti-inflammatory treatment, pelvic-floor physical therapy and treatment of other pain-related or sexual symptoms. There is no single prostatitis treatment that is appropriate for every patient.
01. How Is Prostatitis Treatment Chosen?
Why does the type of prostatitis matter before treatment starts?
The word prostatitis covers conditions with very different biological mechanisms.
A patient with bacterial infection needs a fundamentally different treatment from a patient whose chronic pelvic pain is driven by pelvic-floor dysfunction, nerve sensitization or another noninfectious mechanism.
The major treatment groups are:
- acute bacterial prostatitis: urgent infection-directed treatment;
- chronic bacterial prostatitis: longer culture-guided antibiotic treatment;
- CP/CPPS: individualized multimodal treatment directed at pain, urinary symptoms, pelvic-floor findings and associated problems.
This is why treatment logically follows the prostatitis diagnostic process rather than beginning with the same medicine for every patient.
| Clinical condition | Main treatment target | Common treatment components | What should not be assumed |
|---|---|---|---|
| Acute bacterial prostatitis | Control an acute bacterial prostate infection and prevent systemic complications. | Antibiotics, hydration, assessment of urinary drainage, treatment of sepsis or abscess when present. | That this is simply a pain syndrome that can be observed without infection treatment. |
| Chronic bacterial prostatitis | Eradicate or suppress a documented persistent bacterial infection. | Culture-guided prostate-penetrating antibiotics and evaluation of recurrent urinary infection. | That pelvic pain alone proves bacteria are still present. |
| CP/CPPS | Reduce chronic pain and improve urinary, muscular, sexual and functional symptoms. | Alpha blockers when voiding symptoms are present, pain treatment, pelvic-floor therapy, exercise/lifestyle strategies and selected adjunctive treatments. | That persistent pain automatically represents a hidden infection. |
Can more than one treatment be needed at the same time?
Yes.
This is particularly common in CP/CPPS.
A man may have:
- pelvic-floor muscle tenderness;
- urinary hesitancy;
- pain after ejaculation;
- poor sleep;
- and pain-related activity avoidance
at the same time.
Treating only one domain may therefore leave several clinically important contributors untouched.
Current chronic-pelvic-pain guidance emphasizes a multimodal approach in which treatment is selected according to the dominant clinical features.
02. How Are Acute and Chronic Bacterial Prostatitis Treated?
How is acute bacterial prostatitis treated?
Acute bacterial prostatitis is treated as an acute bacterial urinary infection involving prostate tissue.
Antibiotic treatment should be started promptly when the clinical presentation supports the diagnosis.
Current EAU guidance describes antimicrobial treatment as life-saving in acute bacterial prostatitis.
The exact initial antibiotic depends on factors including:
- how sick the patient is;
- the likely urinary pathogens;
- local antimicrobial resistance;
- recent antibiotic exposure;
- kidney function;
- drug allergies;
- healthcare or catheter exposure;
- and urine-culture results when available.
Does everyone with acute prostatitis need intravenous antibiotics?
No.
The severity of illness matters.
Patients who are systemically ill, unable to maintain oral treatment or have a complicated infection are more likely to need hospital-level care and intravenous antibiotics.
EAU guidance recommends parenteral high-dose bactericidal antimicrobial treatment for systemically ill acute bacterial prostatitis, using agents selected for systemic urinary infection and local resistance patterns.
Once infection parameters improve, patients can often transition to an appropriate oral antibiotic.
How long are antibiotics used for acute bacterial prostatitis?
Current EAU bacterial-prostatitis guidance describes treatment continuing for a total of approximately two to four weeks after initial parenteral therapy and transition to oral treatment when clinically appropriate.
This is a general guideline range—not a reason to self-select an antibiotic or duration.
Duration can change according to:
- infection severity;
- culture results;
- clinical response;
- antibiotic susceptibility;
- prostate abscess;
- urinary obstruction;
- or another complication.
What else is treated besides the bacteria?
Supportive and complication-directed care can also be necessary.
This may include:
- adequate fluid management;
- pain and fever control;
- monitoring for sepsis;
- assessment of bladder emptying;
- urinary drainage when retention develops;
- and imaging or drainage if a prostate abscess is suspected.
Complete inability to urinate is not something to manage at home.
How is chronic bacterial prostatitis treated?
Chronic bacterial prostatitis also requires antibiotics, but the treatment problem is different.
The infection is persistent or recurrent, and the antibiotic must both:
- match the causative organism;
- and achieve useful concentrations within prostate tissue and prostate secretions.
Culture-guided treatment is therefore preferred.
Which antibiotics are used for chronic bacterial prostatitis?
Current EAU guidance recommends a fluoroquinolone such as ciprofloxacin or levofloxacin as first-line treatment for typical chronic bacterial prostatitis when the organism, local resistance pattern and patient-specific safety considerations make that treatment appropriate.
The guideline suggests approximately four to six weeks for standard fluoroquinolone treatment.
If a specific atypical organism is identified, treatment changes.
For example, guideline-directed therapy can include:
- a macrolide or tetracycline for appropriate intracellular organisms;
- or metronidazole when Trichomonas vaginalis is established as the cause.
The principle is more important than memorizing an antibiotic: the organism and susceptibility profile should direct treatment.
What if chronic bacterial prostatitis keeps returning?
Recurrent infection should trigger reassessment rather than automatic repetition of the same prescription.
Clinicians may review:
- whether the same organism is recurring;
- whether antibiotic resistance has developed;
- whether the original antibiotic reached adequate prostate concentrations;
- whether treatment was completed;
- whether urinary obstruction or residual urine is present;
- whether urinary stones or instrumentation are contributing;
- and whether the current symptoms are actually still being driven by bacteria.
The last question matters because persistent pelvic pain after treatment can shift the clinical picture toward CP/CPPS rather than persistent bacterial disease.
03. How Are Alpha Blockers, Pain Treatment and Pelvic-Floor Therapy Used for CP/CPPS?
Why are antibiotics not the whole treatment for chronic prostatitis?
Because many men using the term “chronic prostatitis” actually have CP/CPPS, where an ongoing bacterial infection does not explain the syndrome.
When cultures and appropriate infection testing do not support bacteria, treatment needs to address the symptoms and mechanisms that are actually present.
These can include:
- voiding dysfunction;
- pelvic-floor muscle overactivity;
- myofascial trigger points;
- inflammatory pain;
- neuropathic or centralized pain;
- painful ejaculation;
- sleep disturbance;
- reduced physical activity;
- and the psychological burden of persistent pain.
What do alpha blockers do?
Alpha blockers relax alpha-adrenergic smooth muscle in the prostate/bladder-neck region and can improve aspects of urinary flow and voiding.
Examples include:
- tamsulosin;
- alfuzosin;
- doxazosin;
- terazosin;
- and silodosin.
They do not kill bacteria.
They are also not primarily muscle relaxants for the pelvic floor.
Who may benefit most from an alpha blocker?
The strongest practical reason to use an alpha blocker in CP/CPPS is the presence of voiding symptoms.
The 2025 AUA male chronic-pelvic-pain guideline recommends offering an alpha blocker to patients with CP/CPPS who have voiding symptoms.
EAU evidence also finds a moderate overall benefit for alpha blockers in prostate pain syndrome, although the effect appears less convincing in long-standing disease and may be more useful when urinary dysfunction is an important part of the phenotype.
Possible adverse effects depend on the drug and can include:
- dizziness;
- lower blood pressure;
- fatigue;
- nasal congestion;
- and ejaculatory changes with some agents.
An alpha blocker therefore makes the most sense when there is a symptom target to treat rather than simply because a patient has pelvic pain.
Do anti-inflammatory medicines help?
They can help selected patients.
Current EAU evidence shows a moderate overall treatment effect from anti-inflammatory drugs in primary prostate pain syndrome.
The 2025 AUA guideline also allows anti-inflammatory treatment as one part of a multimodal pain-management strategy.
Commonly used nonsteroidal anti-inflammatory drugs can reduce pain during some symptom periods, but they are not a universal cure.
Long-term use requires caution because NSAIDs can affect:
- the stomach and gastrointestinal tract;
- kidney function;
- blood pressure;
- and cardiovascular risk in susceptible patients.
What other pain treatments are considered?
Pain treatment should match the suspected pain mechanism.
Depending on the patient, a clinician may consider:
- acetaminophen or another non-opioid analgesic;
- anti-inflammatory treatment;
- selected medicines used for neuropathic pain;
- physical therapy;
- behavioral pain-management strategies;
- or referral to a specialist pain service when pain remains disabling.
No single neuropathic-pain medicine has proven universal efficacy in CP/CPPS.
Treatment should be continued only when it produces meaningful improvement in pain, function or quality of life without unacceptable adverse effects.
What does pelvic-floor physical therapy involve?
Pelvic-floor physical therapy can be particularly valuable when examination identifies pelvic-floor overactivity, tenderness or myofascial trigger points.
Therapy may include:
- manual myofascial techniques;
- trigger-point work;
- learning to relax rather than constantly contract the pelvic floor;
- diaphragmatic breathing;
- stretching shortened muscles;
- movement and posture rehabilitation;
- and biofeedback in selected patients.
What is pelvic-floor biofeedback?
Biofeedback uses measurements of muscle activity to help a patient recognize when the pelvic floor is contracting and learn how to reduce unnecessary muscle activation.
This can be useful when a patient unconsciously holds the pelvic floor tense during pain, stress or urination.
EAU evidence includes randomized data in which pelvic-floor relaxation and biofeedback produced more persistent improvement after treatment than a conventional regimen in selected chronic prostate-pain patients.
Should antibiotics ever be used in CP/CPPS?
The answer is more nuanced than “always” or “never.”
Some guideline evidence allows a limited empirical antimicrobial trial in selected treatment-naïve patients early in a prostate-pain syndrome, partly because an unrecognized pathogen can occasionally be present.
But antibiotics should not become indefinite treatment for chronic pelvic pain when:
- urine cultures remain negative;
- appropriate STI testing is negative;
- a previous adequate antibiotic trial has failed;
- and the clinical pattern fits nonbacterial CP/CPPS.
Current EAU guidance specifically emphasizes avoiding unnecessary antibiotic use and moving to other treatment options after an unsuccessful appropriate course.
Repeated antibiotics can expose a patient to adverse effects and increase antimicrobial resistance while leaving pelvic-floor or pain mechanisms untreated.
Can lifestyle and exercise help?
They can be useful components of treatment.
The AUA guideline allows discussion of lifestyle modification and aerobic exercise for CP/CPPS.
Practical strategies may include:
- regular tolerable physical activity;
- reducing prolonged sitting if it reliably provokes perineal pain;
- maintaining consistent sleep;
- treating constipation or excessive bowel straining when relevant;
- using warm baths if they provide symptomatic relief;
- and identifying personal food or drink triggers rather than imposing a universal restrictive diet.
The response is individual.
Can psychological treatment be part of prostatitis care?
Yes, particularly when chronic pain has created significant distress, fear, depression, anxiety or avoidance of normal activities.
This does not mean the pain is psychological or imaginary.
Chronic-pain-focused cognitive and behavioral approaches can help reduce:
- pain-related fear;
- catastrophizing;
- avoidance of movement or sex;
- sleep disruption;
- and the functional impact of living with recurrent symptoms.
EAU guidance recommends chronic-pelvic-pain-focused psychological treatment when significant psychological distress is present.
What about surgery for CP/CPPS?
Prostate surgery is not a routine treatment for CP/CPPS.
Removing or resecting prostate tissue does not address many of the muscular, peripheral nerve or central pain mechanisms involved in chronic pelvic pain.
Surgery may still be appropriate when another separate indication exists, such as clinically important bladder outlet obstruction or another prostate disease, but it should not be performed simply on the assumption that removing prostate tissue will cure unexplained pelvic pain.
04. How Long Does Prostatitis Treatment Take and What Happens if Symptoms Return?
How quickly does acute bacterial prostatitis improve?
There is no identical recovery timetable for every patient.
When the antibiotic is active against the infecting organism and there is no uncontrolled complication, fever and systemic illness should begin to improve.
Pelvic discomfort, urinary irritation and fatigue can take longer to settle because inflamed prostate tissue requires time to recover.
Failure to improve as expected should prompt reassessment for possibilities such as:
- antibiotic resistance;
- prostate abscess;
- urinary obstruction;
- another infection source;
- or an incorrect initial diagnosis.
What if pain remains after the infection has been treated?
Persistent pain does not automatically prove persistent bacteria.
The clinical question should be reopened.
A patient may have:
- slowly resolving inflammation;
- a recurrent bacterial infection;
- pelvic-floor muscle dysfunction;
- neuropathic pain;
- or a transition toward a chronic pelvic-pain syndrome.
Repeat microbiology becomes especially important before assuming that another antibiotic course is necessary.
How is treatment response measured in CP/CPPS?
Pain intensity matters, but it should not be the only outcome.
Useful treatment goals include:
- lower pain intensity;
- fewer or shorter flares;
- less painful ejaculation;
- improved urinary flow or urgency;
- better pelvic-floor relaxation;
- better sleep;
- greater ability to sit, exercise and work;
- return to sexual activity;
- and improved overall quality of life.
The NIH Chronic Prostatitis Symptom Index can be used to track pain, urinary symptoms and quality-of-life burden over time.
Should treatment continue forever if it is not helping?
No.
A treatment plan should be reassessed when there is no meaningful clinical benefit.
For example:
- an antibiotic should not be repeatedly renewed merely because pain persists when cultures remain negative;
- an alpha blocker should be reconsidered if there was no relevant urinary symptom target or no benefit;
- an NSAID should not be continued indefinitely when adverse-effect risk outweighs improvement;
- and physical therapy should be individualized when the examination does not support the assumed muscular mechanism.
Chronic pelvic-pain management is often iterative: treat a plausible contributor, measure the response and modify the plan.
When should someone seek urgent care during treatment?
Urgent assessment is appropriate for:
- high or persistent fever;
- shaking chills;
- confusion;
- marked weakness or faintness;
- rapidly worsening illness;
- complete inability to urinate;
- persistent vomiting;
- or severe symptoms suggesting systemic infection.
Those findings are not typical of an uncomplicated chronic pelvic-pain flare.
Can prostatitis treatment affect PSA?
If active inflammation or infection has raised PSA, the level may fall as the inflammatory episode resolves.
A decrease after treatment does not prove that prostate cancer is absent, just as an elevated PSA during infection does not diagnose cancer.
The relationship between inflammation and PSA is explained in Can Prostatitis Raise PSA?.
What is a realistic treatment goal?
The goal depends on the diagnosis.
For bacterial prostatitis, the primary goal is control or eradication of infection and prevention of complications.
For CP/CPPS, meaningful goals can include:
- less pain;
- fewer symptom flares;
- easier urination;
- less painful ejaculation;
- normalization of pelvic-floor muscle function;
- better sleep;
- less fear of activity;
- and a return to normal work, exercise and sexual life.
Chronic pain treatment is often most successful when progress is measured in both symptoms and function.
Which Prostatitis Treatment Is Used for Which Problem?
| Treatment | What it targets | Where it may fit | Important limitation |
|---|---|---|---|
| Antibiotics | Bacterial infection. | Acute bacterial prostatitis and chronic bacterial prostatitis; limited selected early use in treatment-naïve prostate pain according to some guidance. | Repeated courses are inappropriate when infection testing is negative and an adequate trial has failed. |
| Intravenous antibiotics | Severe/systemic bacterial infection. | Systemically ill acute bacterial prostatitis. | Not routine treatment for stable chronic pelvic pain. |
| Culture-directed antibiotics | A documented pathogen. | Chronic bacterial prostatitis and recurrent urinary infection. | Drug choice must consider susceptibility, prostate penetration and safety. |
| Alpha blockers | Prostate/bladder-neck smooth-muscle tone and voiding symptoms. | CP/CPPS with urinary hesitancy, weak flow or other voiding symptoms. | They do not treat bacteria or every cause of pelvic pain. |
| NSAIDs / anti-inflammatory therapy | Pain and inflammatory pathways. | Selected CP/CPPS patients and short-term pain control. | Benefit is usually moderate; gastrointestinal, kidney and cardiovascular risks matter. |
| Other non-opioid analgesics | Symptom control. | Selected chronic pelvic-pain presentations. | Should improve function or pain enough to justify continued use. |
| Neuropathic-pain medicines | Peripheral or centrally mediated pain mechanisms. | Selected patients with neuropathic features. | Evidence in CP/CPPS varies considerably by agent. |
| Pelvic-floor physical therapy | Muscle overactivity, trigger points and impaired relaxation. | CP/CPPS with pelvic-floor myalgia. | Requires correct muscular diagnosis; generic strengthening is not always appropriate. |
| Biofeedback | Awareness and control of pelvic-floor muscle activity. | Selected patients with overactive pelvic-floor patterns. | Works best as part of a broader rehabilitation plan. |
| Aerobic activity / lifestyle modification | Function, conditioning and individual symptom triggers. | Many CP/CPPS treatment plans. | There is no universal prostatitis diet or trigger list. |
| Chronic-pain-focused psychological treatment | Pain coping, fear, distress and functional impact. | Chronic pelvic pain with significant psychological burden. | Its use does not imply that the pain is imaginary. |
| Urinary drainage | Acute inability to empty the bladder. | Complicated acute bacterial prostatitis. | Requires medical management. |
| Abscess drainage | Localized infected fluid collection. | Selected prostate abscesses. | Not required for routine prostatitis without an abscess. |
| Prostate surgery | A separate structural or prostate indication. | Only when another legitimate indication exists. | Not routine treatment solely for CP/CPPS pain. |
Common Questions About Prostatitis Treatment
| Question | Practical answer |
|---|---|
| What is the best treatment for prostatitis? | There is no single best treatment. Treatment depends on whether the condition is acute bacterial, chronic bacterial or CP/CPPS. |
| Do all forms of prostatitis need antibiotics? | No. Bacterial prostatitis does; CP/CPPS usually requires broader noninfectious pain and urinary management. |
| Are antibiotics necessary for acute bacterial prostatitis? | Yes. Prompt antimicrobial treatment is central to management. |
| Can severe acute prostatitis require IV antibiotics? | Yes, particularly when systemic illness is present. |
| How long is acute bacterial prostatitis treated? | Current EAU guidance describes a total antibiotic course of approximately two to four weeks, individualized to clinical response and complications. |
| How long is chronic bacterial prostatitis treated? | EAU guidance generally recommends approximately four to six weeks for standard fluoroquinolone treatment when appropriate. |
| Should chronic bacterial treatment be culture-guided? | Yes. Culture and susceptibility information are important. |
| Why is chronic bacterial treatment longer? | The drug must reach the infected prostate compartment and eradicate a persistent bacterial source. |
| Do alpha blockers treat infection? | No. |
| Why are alpha blockers used for CP/CPPS? | They can improve voiding symptoms in selected patients. |
| Does AUA guidance recommend alpha blockers? | Yes, for CP/CPPS patients who have voiding symptoms. |
| Can NSAIDs help? | They can provide moderate symptom improvement in selected patients but are not a universal long-term solution. |
| Can pelvic-floor therapy help prostatitis symptoms? | Yes, particularly when pelvic-floor overactivity, tenderness or trigger points contribute to CP/CPPS. |
| Should men with pelvic pain simply do Kegel exercises? | No. An overactive painful pelvic floor may need relaxation and lengthening rather than further strengthening. |
| What is pelvic-floor biofeedback? | A method that measures muscle activity and helps patients learn more effective contraction and relaxation patterns. |
| Should antibiotics be repeated every time pelvic pain flares? | No. A flare does not prove recurrent infection. |
| Can exercise help CP/CPPS? | Regular tolerable physical activity can be part of management and is supported as a reasonable lifestyle strategy. |
| Can warm baths help? | Some patients find them useful for symptomatic relief, although they do not treat bacterial infection. |
| Can psychological treatment help? | Yes, when chronic pain causes significant distress or functional disruption. This does not mean the pain is imaginary. |
| Is surgery a normal treatment for CP/CPPS? | No. |
| What if symptoms remain after antibiotics? | The diagnosis should be reassessed rather than automatically assuming persistent infection. |
| What if fever continues despite treatment? | The patient needs reassessment for resistant infection, obstruction, abscess or another complication. |
| Can prostatitis treatment lower PSA? | PSA may fall as prostate inflammation resolves, but this does not by itself rule out other prostate conditions. |
| Can CP/CPPS improve? | Yes. Treatment can reduce pain and flares and improve urinary, sexual and daily function, although recovery is often gradual. |
Summary
- Prostatitis treatment depends on the subtype rather than the symptom label alone.
- Acute bacterial prostatitis is a true bacterial infection that requires prompt antimicrobial treatment.
- Systemically ill patients with acute bacterial prostatitis may require intravenous antibiotics and hospital-level assessment.
- Urine culture helps identify the responsible pathogen and guide treatment.
- Current EAU guidance describes a total acute bacterial prostatitis treatment course of approximately two to four weeks after appropriate initial treatment and clinical improvement.
- Urinary retention, sepsis and prostate abscess can change the acute treatment plan.
- Chronic bacterial prostatitis is treated with longer courses of antibiotics that both match the organism and penetrate prostate tissue.
- Culture-guided therapy is preferred for chronic bacterial prostatitis.
- Current EAU guidance recommends a fluoroquinolone as first-line treatment for typical chronic bacterial prostatitis when clinically appropriate.
- The typical guideline duration for chronic bacterial prostatitis is approximately four to six weeks.
- Atypical organisms require organism-specific antimicrobial treatment.
- Antibiotic resistance and drug safety must be considered before prescribing.
- Persistent pain after antibiotics does not necessarily mean bacteria remain in the prostate.
- CP/CPPS generally requires multimodal treatment rather than infection-only treatment.
- Alpha blockers are used primarily when voiding symptoms are part of CP/CPPS.
- The 2025 AUA male chronic-pelvic-pain guideline recommends offering an alpha blocker to CP/CPPS patients with voiding symptoms.
- EAU evidence finds a moderate overall benefit from alpha blockers in primary prostate pain syndrome.
- Anti-inflammatory treatment can provide moderate symptom benefit in selected CP/CPPS patients.
- Long-term NSAID risks must be considered.
- Other non-opioid and neuropathic-pain strategies can be considered according to the suspected pain mechanism.
- Pelvic-floor physical therapy can be important when muscle overactivity, tenderness or trigger points are present.
- Pelvic-floor rehabilitation may focus on relaxation and lengthening rather than strengthening.
- Biofeedback can help selected patients learn to reduce excessive resting pelvic-floor activity.
- Some guidance permits a limited antibiotic trial in selected treatment-naïve prostate-pain patients early in disease.
- Repeated empirical antibiotics should be avoided when cultures remain negative and an adequate antibiotic course has already failed.
- Regular activity, sleep management and individualized trigger modification can support recovery.
- There is no universal prostatitis diet.
- Chronic-pain-focused psychological treatment can help when persistent symptoms cause significant distress or functional impairment.
- Psychological treatment does not imply that pelvic pain is imaginary.
- Prostate surgery is not routine treatment for CP/CPPS.
- A return of pain does not automatically indicate a return of infection.
- Treatment response in CP/CPPS should include urinary function, pain, pelvic-floor control, sexual function and overall daily function.
- High fever, shaking chills, inability to urinate, confusion or rapidly worsening illness require prompt medical assessment.
- The strongest treatment plan identifies which symptom or biological mechanism each treatment is intended to address and stops therapies that do not provide meaningful benefit.
Educational disclaimer: This article provides general medical education about prostatitis treatment. Antibiotic selection, treatment duration, alpha blockers, anti-inflammatory medicines and other prescription therapies require individual assessment of the diagnosis, microbiology, kidney function, other medicines, allergies and treatment risks. Acute bacterial prostatitis can become a serious systemic infection. Fever, shaking chills, confusion, inability to urinate or rapidly worsening illness requires prompt medical assessment rather than self-treatment.
Explore the Prostatitis Pathway
Treatment should follow a clear diagnosis. For urine testing, cultures, prostate examination and pelvic-floor evaluation, see How Is Prostatitis Diagnosed?.
For the broader framework separating infection, inflammation and chronic pelvic pain, see Prostatitis and Prostate Pain.
When symptoms begin abruptly with fever and acute urinary difficulty, see Acute Bacterial Prostatitis.
When recurrent cultures demonstrate a persistent bacterial source, see Chronic Bacterial Prostatitis.
When long-lasting pelvic pain continues without an established bacterial infection, see Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS).
The next guide compares prostatitis and urinary tract infection, including symptom overlap, urine-culture findings, fever, prostate involvement and why the treatments are not always identical.
Evidence Sources
- European Association of Urology. Urological Infections Guidelines — Acute and Chronic Bacterial Prostatitis: Antimicrobial Treatment and Supportive Management.
- European Association of Urology. Chronic Pelvic Pain Guidelines — Primary Prostate Pain Syndrome, Alpha Blockers, Anti-Inflammatory Treatment, Pelvic-Floor Therapy and Multimodal Management.
- American Urological Association. Male Chronic Pelvic Pain: Guideline Part II — Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Journal of Urology. 2025.
- American Urological Association. Male Chronic Pelvic Pain: Guideline Part I — Evaluation and Management Approach. Journal of Urology. 2025.
- National Institute of Diabetes and Digestive and Kidney Diseases. Prostate Problems — Treatment of Bacterial Prostatitis and Chronic Prostatitis.
